COVID-19, an infection caused by the new coronavirus SARS-CoV-2, is associated with a
number of pathophysiological mechanisms, mobilizing a wide spectrum of biomolecules …

To investigate the immune status of people who previously had COVID‐19 infections, we
recruited two‐week postrecovery patients and analyzed circulating cytokine and lymphocyte …

Objectives Cytokine dysregulation has been proposed as one of the main culprits for severe
COVID-19 and poor prognosis. We examined the parallel presence of lymphopoietic …

Introduction: The aim of this study was to evaluate the immune and inflammatory responses
in COVID-19 patients by dosing specific IgM and IgG total antibodies and interleukin 6 …

Background: SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is
recognized for the first time in Wuhan, China. The cytokine storm is a known factor causing …

This study aimed to determine the specific cytokine profile in peripheral blood during the
early onset of COVID-19 infection. This was a cross-sectional exploratory, single center …

Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may
represent disease severity. We aimed to assess plasma inflammatory mediator …

This study attempted to explore pro-inflammatory and anti-inflammatory responses in
patients with mild/moderate coronavirus disease 19 (COVID-19). Eight pro-inflammatory (IL …

Background The lack of knowledge regarding the pathogenesis and host immune response
during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we …

Lymphopenia, T cell subgroup changes, and cytokine level differences are important in the
early diagnosis and treatment of Covid‐19 cases and similar pandemics. We aimed to …